$47.6 M

VIRI Mkt cap, 20-Jul-2021
Virios Therapeutics Net income (Q1, 2021)-3.1 M
Virios Therapeutics EBIT (Q1, 2021)-3.1 M
Virios Therapeutics Cash, 31-Mar-202124.6 M
Get notified regarding key financial metrics and revenue changes at Virios TherapeuticsLearn more
Banner background

Virios Therapeutics Income Statement

Annual

USDFY, 2018FY, 2019

R&D expense

854.1k836.2k

General and administrative expense

1.1m1.3m

Operating expense total

2.0m2.2m

EBIT

(2.0m)(2.2m)

Interest expense

152.1k295.1k

Pre tax profit

(2.1m)(2.5m)

Net Income

(2.1m)(2.5m)

EPS

(0.5)

Quarterly

USDQ3, 2019Q3, 2020Q1, 2021

R&D expense

392.8k108.1k1.7m

General and administrative expense

343.5k2.6m1.4m

Operating expense total

736.3k2.7m3.1m

EBIT

(736.3k)(2.7m)(3.1m)

Interest expense

75.5k104.4k1.4k

Pre tax profit

(811.8k)(2.7m)(3.1m)

Net Income

(811.8k)(2.7m)(3.1m)

EPS

(0.6)

Virios Therapeutics Balance Sheet

Annual

USDFY, 2018FY, 2019

Cash

30.0k309.4k

Prepaid Expenses

12.0k5.7k

Current Assets

42.4k315.9k

Total Assets

65.9k315.9k

Accounts Payable

145.7k35.4k

Current Liabilities

1.3m1.6m

Total Liabilities

1.3m5.3m

Preferred Stock

1.3m75.0k

Additional Paid-in Capital

12.6m12.6m

Retained Earnings

(15.1m)(17.6m)

Total Equity

(2.5m)(5.0m)

Financial Leverage

0 x-0.1 x

Quarterly

USDQ3, 2020Q1, 2021

Cash

499.1k24.6m

Prepaid Expenses

61.0k3.7m

Current Assets

560.1k28.3m

Total Assets

785.4k28.3m

Accounts Payable

199.4k614.7k

Current Liabilities

1.8m1.2m

Total Liabilities

5.9m1.2m

Common Stock

833.0

Preferred Stock

75.0k

Additional Paid-in Capital

16.2m58.1m

Retained Earnings

(21.5m)(31.0m)

Total Equity

(5.2m)27.1m

Financial Leverage

-0.2 x1 x

Virios Therapeutics Cash Flow

Annual

USDFY, 2018FY, 2019

Net Income

(2.1m)(2.5m)

Accounts Payable

65.6k(89.8k)

Cash From Operating Activities

(1.2m)(2.1m)

Cash From Financing Activities

1.2m2.4m

Net Change in Cash

(45.5k)279.4k

Quarterly

USDQ3, 2019Q3, 2020Q1, 2021

Net Income

(1.8m)(3.8m)(3.1m)

Accounts Payable

(74.3k)156.1k530.8k

Cash From Operating Activities

(1.6m)(1.6m)(5.1m)

Cash From Financing Activities

1.8m1.8m(97.6k)

Net Change in Cash

176.6k189.7k(5.2m)

Interest Paid

3.0k

Virios Therapeutics Ratios

USDFY, 2018

Virios Therapeutics Operating Metrics

Nov, 2020

Patents (US)

12

Patents (Foreign)

8